FdaApplication
ANDA 212346
Identifiers
- fda_app_no: ANDA212346
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2020-09-10 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% | DEXTROSE; POTASSIUM CHLORIDE | 5GM/100ML;75MG/100ML | INJECTABLE;INJECTION |
| DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% | DEXTROSE; POTASSIUM CHLORIDE | 5GM/100ML;150MG/100ML | INJECTABLE;INJECTION |
2 products